SWTX
SpringWorks Therapeutics (SWTX)
$84
About SpringWorks Therapeutics (SWTX)
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.
Details
Daily high
$51.01
Daily low
$47.80
Price at open
$51.01
52 Week High
$62.00
52 Week Low
$28.21
Market cap
3.7B
Dividend yield
0.00%
Volume
1.4M
Avg. volume
2.7M
P/E ratio
-14.31
SpringWorks Therapeutics News
Details
Daily high
$51.01
Daily low
$47.80
Price at open
$51.01
52 Week High
$62.00
52 Week Low
$28.21
Market cap
3.7B
Dividend yield
0.00%
Volume
1.4M
Avg. volume
2.7M
P/E ratio
-14.31